GSK3B and type 2 diabetes mellitus: It was reported that higher peripheral circulating GSK-3β was negatively correlated with cognitive scores in diabetes patients diagnosed with MCI, and it has been proposed as a diagnostic marker for MCI in T2DM patients [80].